Capital Markets
Competition & Regulatory
Corporate / M&A
Data Protection & Privacy
Energy & Infrastructure
Employment & Benefits
Family Owned Business & Private Wealth
Investment Management
Litigation & Risk Management
Public & Administrative Law
Real Estate
Restructuring & Insolvency
Tax
Technology & IP
Rapid transformation in the Life Sciences & Healthcare industry requires organisations to strike a balance between market potential, policy compliance and patient demands with continued innovation.
We are all affected by this sector and it falls under heavy social and political scrutiny. Regulation of competition in the sector has also made it increasingly dynamic and challenging. As the demand for life sciences and healthcare services is ever-growing, so too are the strains and scrutiny placed on its decision makers.
With the largest Life Sciences & Healthcare Team in de Dutch market, we can relate to our clients and deliver top tier services to our clients during all the stages of business lifecycle.
Recent changes in the Dutch healthcare system have allowed investors and care providers to operate from the Netherlands when deploying innovative care concepts. The relocation of the EMA to Amsterdam attracts also new pharmaceutical companies and generates a lot of activity.
Remodelling of the healthcare system has resulted in hospital mergers, partnerships, and reorganisation of healthcare. Besides that, E-Health plays an increased role in prevention and screening. This growth in innovation is evident across other Loyens & Loeff markets in Belgium, Switzerland and Luxembourg.
Successfully developing and marketing products in the pharmaceutical and life sciences sectors requires first-rate legal and tax support. This support must include an expert understanding of clinical research, intellectual property, tax planning, regulatory compliance, and pricing issues.
The implications of the COVID-19 pandemic reach across borders, industries, and legal disciplines. That is why Loyens & Loeff has set up dedicated expert teams - to offer you an integrated answer to all your legal and tax questions related to the coronavirus outbreak.
Op 12 maart 2020 werd door het kabinet aangekondigd dat vanwege COVID-19 iedereen die daartoe in staat was de komende twee weken thuis moest werken.
The COVID-19 crisis has emphasised the importance of having performant insolvency proceedings. As of now, new measures are in force which aim to optimise the judicial reorganisation procedure.
Digital transformation is all about using the latest technology to improve your business model. Digital technology creates new business opportunities which in turn creates a whole new range of tax and legal challenges such as contracting, data protection, privacy questions, intellectual property, consumer protection and competition issues.
The speed at which digital technology has become an integral part of our daily lives has overtaken most legislative processes. In recent years, the European Union, Member-States and international legislative bodies have therefore increased their regulatory efforts.
SMSG published its advice on potential practical challenges that may arise in the implementation of the Digital Operational Resilience Act.
A European Parliament committee that deals with the topics of civil liberties and justice has criticised a proposed data protection framework between the EU and the U.S.
